| Sharon K Cashman, RPH | |
|
312 9th St Sw Ste 1000, Waverly, IA 50677-2916 | |
| (319) 483-4100 | |
| (319) 483-4101 |
| Full Name | Sharon K Cashman |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 312 9th St Sw Ste 1000, Waverly, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124169206 | NPI | - | NPPES |
| 16896 | Other | IA | PHARMACIST LICENSE # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 16896 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sharon K Cashman, RPH 312 9th St Sw Ste 10000, Waverly, IA 50677-2929 Ph: (319) 483-4100 | Sharon K Cashman, RPH 312 9th St Sw Ste 1000, Waverly, IA 50677-2916 Ph: (319) 483-4100 |
News Archive
Invasive and costly tests commonly performed on women before surgery for stress urinary incontinence (SUI) may not be necessary, according to researchers at the University of California San Diego, School of Medicine and the Urinary Incontinence Treatment Network. The study, supported by the National Institutes of Health (NIH), will be released online May 2 by the New England Journal of Medicine.
A transportation review written by a professor from the Berlin School of Economics and Law presents a way of analyzing the predicted impacts epidemic outbreaks have on global supply chains and describes the results of a simulation-based analysis of COVID-19 (SARS-CoV-2) as an example.
"Meaningful biogenerics legislation should be the first stop for policymakers tasked with financing health reform. PCMA and a broad coalition of consumers, employers, labor unions, and others support bipartisan legislation that would create a regulatory pathway for the Food and Drug Administration to approve generic versions of biologic products."
Currently, the limited efficacy of conventional therapies, especially in the case of several oncology and autoimmune and inflammatory disorders (AIID), is creating the need for safe and effective treatment alternatives.
Bristol-Myers Squibb Company and Mead Johnson Nutrition Company announced today that based on preliminary results the offer by Bristol-Myers Squibb to exchange up to 170,000,000 shares of common stock of Mead Johnson for outstanding shares of Bristol-Myers Squibb common stock that are validly tendered and not validly withdrawn was oversubscribed. The exchange offer expired at 12:00 midnight, New York City time, on December 17, 2009.
› Verified 9 days ago
Colleen Susan Losey, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 312 9th St Sw, Waverly, IA 50677 Phone: 319-352-4958 Fax: 319-483-4168 | |
Kimberly Hotz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 212 Oak Wood Cir, Waverly, IA 50677 Phone: 319-415-6602 | |
Dr. Ryan Patrick Frerichs, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 110 10th St Sw, Waverly, IA 50677 Phone: 319-352-3120 Fax: 319-352-5720 | |
Dr. Megan Michelle Mormann, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 312 9th St Sw, Waverly, IA 50677 Phone: 319-483-3100 | |
Tamra Litterer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 312 9th St Sw Ste 1000, Waverly, IA 50677 Phone: 319-483-4100 | |
Virginia Kay Fienup, R. PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 110 10th St Sw, Waverly, IA 50677 Phone: 319-352-3126 |